# Vaxxas: Research, Brisbane, Australia

> Vaxxas: Vaxxas Pty Ltd is a clinical-stage biotechnology company based in Brisbane, Queensland, Australia. Based in Brisbane, Australia. Founded 2011.

Source: https://millionrounds.com/startup/vaxxas (Millionrounds; every figure on the page links to its filing or article)

Australia · [Research startup](https://millionrounds.com/companies)

# Vaxxas

Vaxxas Pty Ltd is a clinical-stage biotechnology company based in Brisbane, Queensland, Australia.

Funding reported Last round: Grant

Research Brisbane, Australia

Company summary

- **Founded:** 2011 15 years old
- **Team:** 120 51 to 200 people
- **Funding reported:** 102.5M as listed, currency not stated
- **Last round:** Grant Aug 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Vaxxas has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Vaxxas

Vaxxas Pty Ltd is a clinical-stage biotechnology company based in Brisbane, Queensland, Australia.

Founded in 2011 as a spin-out from the Australian Institute of Bioengineering and Nanotechnology at the University of Queensland, Vaxxas focuses on innovative vaccine delivery solutions. The company employs around 130 people and operates a pilot-scale manufacturing facility in Brisbane, with additional offices in the United States. Vaxxas is known for its proprietary High-Density Microarray Patch (HD-MAP) technology, marketed as the NanopatchTM. This needle-free patch delivers vaccines directly to the skin's immune cells, enhancing immune responses while reducing the required vaccine dosage. The technology also simplifies logistics by eliminating the need for refrigeration. Vaxxas collaborates with major pharmaceutical companies, government agencies, and global organizations to advance its mission of improving vaccine access and effectiveness, particularly in infectious diseases and oncology. The company has secured significant funding to support its growth and commercialization efforts.

## What company datasets say Vaxxas raised

Funding, as reported

Reported in all **102.5M** in the source's currency

Rounds **8**

Last round **Grant**

Last round size **31.9M**

Last round date **Aug 2023**

Investors listed **10**

## The company, in detail

What they build

Known for

health care vaccine efficacy regulatory pathways vaccine logistics innovation project management biotech clinical validation oncology vaccines biotechnology research distribution manufacturing vaccine technology licensing biotech leadership team biotech for infectious diseases vaccine efficacy enhancement microarray patch microarray vaccine technology

Built with from their website

Google Tag Manager LiteSpeed Atlassian Flow Font Awesome Mapp CloudFlare Viewport Meta Element UI GlobeNewswire

+8 more

Google Font API Microsoft Exchange Microsoft Azure Microsoft 365 Apps & Services Mobile Friendly Microsoft Intune jQuery Anthropic Claude

- **Sector:** Research
- **Industry code:** NAICS 541714, 339112, SIC 2834, 8731, 3841
- **Region:** Queensland
- **Revenue:** 90M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/vaxxas)

## Research in Australia

Startups like it

- [**PolyActiva** Melbourne · founded 2010 *Raised*](https://millionrounds.com/company/polyactiva)
- [**Ferronova** Adelaide · founded 2016 *Raised*](https://millionrounds.com/company/ferronova)
- [**Nbryo** Brisbane · founded 2020 *Raised*](https://millionrounds.com/company/nbryo)
- [**Fremantle Seaweed** Perth *Raised*](https://millionrounds.com/company/fremantle-seaweed)
- [**Bovotica** Brisbane · founded 2023 *Raised*](https://millionrounds.com/company/bovotica)
- [**Bower** Byron Bay · founded 2025 *Raised*](https://millionrounds.com/company/bower)
- [**Levur** Sydney · founded 2023 *Raised*](https://millionrounds.com/company/levur)
- [**Cell Bauhaus** Melbourne · founded 2023 *Raised*](https://millionrounds.com/company/cell-bauhaus)

## Is this your company?

Add your raise, your deck and your story, and put Vaxxas in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)